Da Cheng Qi Decoction attenuates LPS-induced intestinal injury in rats in association with modulation of CHI3L1-associated inflammatory signaling and metabolic alterations
Digestion · 05.11.2026
DOI: 10.1159/dig/acmag036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, online erschienen am 05.11.2026. Verfasst von daorong wu und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Sepsis-induced intestinal injury (SII) is a life-threatening gastrointestinal complication characterized by intestinal barrier dysfunction, metabolic disturbance, and excessive inflammation, while effective targeted interventions remain limited. Da Cheng Qi Decoction (DCQD), a classical East Asian traditional medicine formula, has shown protective effects against sepsis-associated intestinal dysfunction; however, the molecular networks underlying its effects remain incompletely understood. Here, we integrated metabolomic and proteomic analyses with experimental validation to investigate the potential regulatory mechanisms associated with DCQD-mediated protection against SII.
Methods
A rat SII model was established in male Sprague-Dawley rats by LPS induction, and an in vitro intestinal injury model was generated using LPS-stimulated human colonic epithelial cells (CCD841). Integrated metabolomic and proteomic profiling of ileal tissues, together with in vivo and in vitro validation experiments, was performed to characterize DCQD-associated metabolic and inflammatory alterations and identify potential molecular networks involved in its protective effects.
Results
Multi-omics identified 11 altered metabolites and 22 differentially expressed proteins after DCQD treatment, with CHI3L1 prioritized as a candidate molecule through exploratory multi-omics analysis and associated with bile acid and glucose metabolism (P < 0.05). In vitro, CHI3L1 silencing or DCQD-containing serum alleviated LPS-induced cellular injury (P < 0.01), and combined intervention showed enhanced protective effects on CCD841 cells, including improved cell viability, reduced apoptosis, and decreased secretion of IL-6, IL-1β, and TNF-α (all P < 0.05). In vivo, DCQD administration or CHI3L1 silencing ameliorated ileal histopathological injury, reduced inflammatory cytokine levels, improved intestinal barrier-related dysfunction reflected by citrulline and D-lactate levels, and decreased JAK2/STAT3 phosphorylation. These findings suggest that modulation of CHI3L1-associated inflammatory signaling may contribute to the protective effects of DCQD against SII.
Conclusions
The present findings suggest that DCQD attenuates SII and is associated with modulation of metabolic alterations and CHI3L1-associated inflammatory signaling responses. CHI3L1 may represent a potential molecular mediator involved in SII progression and DCQD-mediated protection. These exploratory findings provide preliminary insights into the molecular networks associated with the protective effects of DCQD against septic intestinal injury.
Zitieren
APA
wu, D., hua, T., song, Q., wen, T., & Yang, M. (2026). Da Cheng Qi Decoction attenuates LPS-induced intestinal injury in rats in association with modulation of CHI3L1-associated inflammatory signaling and metabolic alterations. Digestion. https://doi.org/10.1159/dig/acmag036
Vancouver
wu D, hua T, song Q, wen T, Yang M. Da Cheng Qi Decoction attenuates LPS-induced intestinal injury in rats in association with modulation of CHI3L1-associated inflammatory signaling and metabolic alterations. Digestion. 2026. doi:10.1159/dig/acmag036
BibTeX
@article{wu2026,
author = {wu, daorong and hua, tianfeng and song, qiuming and wen, tingyu and Yang, Min},
title = {Da Cheng Qi Decoction attenuates LPS-induced intestinal injury in rats in association with modulation of CHI3L1-associated inflammatory signaling and metabolic alterations},
journal = {Digestion},
year = {2026},
doi = {10.1159/dig/acmag036}
}
EUVIMED